跳至主要内容
临床试验/IRCT138811153278N1
IRCT138811153278N1已完成2 期

The Study of efficacy and tolerability of adjunctive therapy with Zonisamide in adulthood intractable epilepsy

Isfahan University Of Medical Sciences and Health Services0 个研究点目标入组 56 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
56

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
17 years 至 65 years(—)
性别
All

入选标准

  • 1) Sizure Frequency =4per month inspite of treatment with 2 AED( Intractable Seizure)
  • 2) Age above 17
  • 3) Any types of Seizure Disorders
  • Exclusion Critera:
  • 1) Having progressive encephalopathy or any structral disorders of central nervous system now or before takeing part into this study
  • 2) Having any diseases such as eyes, heart, blood, kidney, liver now or before taking part into this study
  • 3) sulfunamide sensitivity
  • 4) Married women in pregnancy ages
  • 5) Using Acetazolamide as an AED
  • 6) Not having any cooperation in using drug
  • 7) Any severe side effects of drug
  • 8) Not having consensus abot continuation of the study

排除标准

  • 未提供

研究者

发起方
Isfahan University Of Medical Sciences and Health Services

相似试验

The Study of efficacy and tolerability of adjunctive... | 临床试验